Package 36800-616-63

{"route": ["ORAL"], "spl_id": "2ebdee8c-703f-4a75-a79a-b908ce54f30d", "openfda": {"nui": ["N0000000151", "N0000175784"], "unii": ["H0G9379FGK", "5QZO15J2Z8", "NBZ3QY004S"], "rxcui": ["283641"], "spl_set_id": ["8ef70327-9a04-413b-b331-f5d3a94d6b36"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Topco Associates LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 TABLET, CHEWABLE in 1 BOTTLE (36800-616-63)", "package_ndc": "36800-616-63", "marketing_start_date": "20160229"}, {"sample": false, "description": "50 TABLET, CHEWABLE in 1 BOTTLE (36800-616-71)", "package_ndc": "36800-616-71", "marketing_start_date": "20160229"}], "brand_name": "topcare dual action complete", "product_id": "36800-616_2ebdee8c-703f-4a75-a79a-b908ce54f30d", "dosage_form": "TABLET, CHEWABLE", "pharm_class": ["Calculi Dissolution Agent [EPC]", "Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "36800-616", "generic_name": "famotidine, calcium carbonate and magnesium hydroxide", "labeler_name": "Topco Associates LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "topcare dual action complete", "active_ingredients": [{"name": "CALCIUM CARBONATE", "strength": "800 mg/1"}, {"name": "FAMOTIDINE", "strength": "10 mg/1"}, {"name": "MAGNESIUM HYDROXIDE", "strength": "165 mg/1"}], "application_number": "ANDA077355", "marketing_category": "ANDA", "marketing_start_date": "20160229", "listing_expiration_date": "20261231"}